Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Lezack Adam. Officer active across 1 company, notably Beta Bionics, Inc.. Aggregated, 6 filings have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €73k. Activity tracked since 15 March 2025. The latest transaction was disclosed on 22 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Lezack Adam is a declarant linked to Beta Bionics, Inc., where he is Director. He has 4 filings in total, and in the 4 sampled recent filings, the transactions are sales for EUR 18189 between 2025-03-18 and 2026-05-26.